Search results for " pancreatic cancer"
ADC Development Robust Despite Lackluster Performance
The company’s first ADC clinical candidate, OMTX705, is being developed for pancreatic cancer and invasive lung and breast cancer. The company has already run pre-clinical trials on the candidate (20)…
Techniques for Improving Process Development for Exosome-Derived Therapeutics
With pancreatic cancer, for instance, the standard of care does not offer much advantage to the patient. Breakthroughs in this area are desperately needed. One cancer treatment with enormous p…
Milestones and Moderate Progress in 2012 Drug Approvals
First gene therapy and plant-based expression vector products approved in 2012. In terms of product approvals, the past year can be considered reasonably successful. Twelve biopharm…